This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neely, J. R. Articles by Feuvray, D. Search for Related Content PubMed PubMed Citation Articles by Neely, J. R. Articles by Feuvray, D.

American Journal of Pathology, Vol 102, 282-291, Copyright © 1981 by American Society for Investigative Pathology

REVIEWS

Metabolic products and myocardial ischemia

JR Neely and D Feuvray

Metabolic products accumulate in ischemic myocardium secondary to reduced coronary flow, which prevents adequate washout of vascular spaces, and to reduced oxidative metabolism. The most notable products that accumulate are NADH, H+, lactate, CO2, long-chain acyl-CoA, and long-chain acyl carnitine. These products interfere with the production of ATP and the functioning of the myocardium. Glycolytic production of ATP is inhibited by accumulation of NADH, H+, and lactate. Mitochondrial and plasma membrane function may be altered by the acyl esters of CoA and carnitine. Mitochondrial membranes become structurally distorted and fragmented, and lipid-containing amorphous densities appear in the matrix. Structural alterations of mitochondria occur more frequently in hearts receiving high concentrations of fatty acids and correlate with high tissue levels of acyl esters of CoA and carnitine. Addition of acyl carnitine to mitochondria isolated from normal hearts results in nodulose-appearing cristae and fragmentation of mitochondrial membranes.

This article has been cited by other articles:

				H. R. Cross Trimetazidine: a novel protective role via maintenance of Na+/K+-ATPase activity? Cardiovasc Res, September 1, 2000; 47(4): 637 - 639. [Full Text] [PDF]

				H. El Banani, M. Bernard, D. Baetz, E. Cabanes, P. Cozzone, A. Lucien, and D. Feuvray Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: Comparison between low- and zero-flow ischaemia Cardiovasc Res, September 1, 2000; 47(4): 688 - 696. [Abstract] [Full Text] [PDF]

				L. L. McLeod and A. I. Alayash Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H92 - H99. [Abstract] [Full Text] [PDF]

				Y. Mitsui, J. D. Schmelzer, P. J. Zollman, M. Kihara, and P. A. Low Hypothermic neuroprotection of peripheral nerve of rats from ischaemia–reperfusion injury Brain, January 1, 1999; 122(1): 161 - 169. [Abstract] [Full Text] [PDF]

				H. H. Klein, S. Pich, R. M. Bohle, J. Wollenweber, and K. Nebendahl Myocardial Protection by Na+-H+ Exchange Inhibition in Ischemic, Reperfused Porcine Hearts Circulation, August 15, 1995; 92(4): 912 - 917. [Abstract] [Full Text]